An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAs

Antiviral Research

Volumn 97, Issue 1, 2013, Pages 10-23

  Ibrišimović, Mirza ^a   Kneidinger, Doris ^a   Lion, Thomas ^a   Klein, Reinhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adenovirus; MicroRNA; RNA interference

Indexed keywords

ADENOVIRUS VECTOR; CIDOFOVIR; DNA POLYMERASE; MICRORNA; VIRUS DNA;

3' UNTRANSLATED REGION; ADENOVIRUS 5; ARTICLE; CONCENTRATION (PARAMETERS); EMBRYO; GENE DOSAGE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROGENY; RNA INTERFERENCE; RNA SEQUENCE; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ADENOVIRIDAE; ANTIVIRAL AGENTS; BIOLOGICAL AGENTS; CELL LINE; CYTOSINE; DRUG SYNERGISM; HUMANS; MICRORNAS; ORGANOPHOSPHONATES; RNA INTERFERENCE; VIRAL LOAD; VIRAL PROTEINS; VIRUS REPLICATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 84870382033     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.10.008     Document Type: Article

References (52)

1. Alba R., Bosch A., Chillon M. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther. 2005, 12(Suppl. 1):S18-S27.
2. Andersson M.G., Haasnoot P.C., Xu N., Berenjian S., Berkhout B., Akusjarvi G. Suppression of RNA interference by adenovirus virus-associated RNA. J. Virol. 2005, 79:9556-9565.
3. Arbuthnot P. Harnessing RNA interference for the treatment of viral infections. Drug News Perspect. 2010, 23:341-350.
4. Blanke C., Clark C., Broun E.R., Tricot G., Cunningham I., Cornetta K., Hedderman A., Hromas R. Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections. Am. J. Med. 1995, 99:326-328.
5. Burnett J.C., Rossi J.J. RNA-based therapeutics: current progress and future prospects. Chem. Biol. 2012, 19:60-71.
6. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Nat. Rev. Mol. Cell Biol. 2009, 136:642-655.
7. Chakrabarti S., Mautner V., Osman H., Collingham K.E., Fegan C.D., Klapper P.E., Moss P.A., Milligan D.W. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002, 100:1619-1627.
8. Chung K.H., Hart C.C., Al-Bassam S., Avery A., Taylor J., Patel P.D., Vojtek A.B., Turner D.L. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res. 2006, 34:e53.
9. Chung Y.S., Kim M.K., Lee W.J., Kang C. Silencing E1A mRNA by RNA interference inhibits adenovirus replication. Arch. Virol. 2007, 152:1305-1314.
10. Cullen B.R. Transcription and processing of human microRNA precursors. Nat. Rev. Mol. Cell Biol. 2004, 16:861-865.
11. Cundy K.C. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin. Pharmacokinetics 1999, 36:127-143.
12. Davidson B.L., McCray P.B. Current prospects for RNA interference-based therapies. Nat. Rev. Genet. 2011, 12:329-340.
13. de Jong R.N., van der Vliet P.C., Brenkman A.B. Adenovirus DNA replication: protein priming, jumping back and the role of the DNA binding protein DBP. Curr. Topics Microbiol. Immunol. 2003, 272:187-211.
14. Ebner K., Rauch M., Preuner S., Lion T. Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR. J. Clin. Microbiol. 2006, 44:2808-2815.
15. Echavarria M. Adenoviruses in immunocompromised hosts. Clin. Microbiol. Rev. 2008, 21:704-715.
16. Eckstein A., Grossl T., Geisler A., Wang X., Pinkert S., Pozzuto T., Schwer C., Kurreck J., Weger S., Vetter R., Poller W., Fechner H. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions. Antiviral Res. 2010, 88:86-94.
17. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
18. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
19. Ghildiyal M., Zamore P.D. Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 2009, 10:94-108.
20. Goncalves M.A., de Vries A.A. Adenovirus: from foe to friend. Rev. Med. Virol. 2006, 16:167-186.
21. Haasnoot J., Westerhout E.M., Berkhout B. RNA interference against viruses: strike and counterstrike. Nat. Biotechnol. 2007, 25:1435-1443.
22. Hale G.A., Heslop H.E., Krance R.A., Brenner M.A., Jayawardene D., Srivastava D.K., Patrick C.C. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 1999, 23:277-282.
23. Hartline C.B., Gustin K.M., Wan W.B., Ciesla S.L., Beadle J.R., Hostetler K.Y., Kern E.R. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. J. Infect. Dis. 2005, 191:396-399.
24. Heemskerk B., Lankester A.C., van Vreeswijk T., Beersma M.F., Claas E.C., Veltrop-Duits L.A., Kroes A.C., Vossen J.M., Schilham M.W., van Tol M.J. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J. Infect. Dis. 2005, 191:520-530.
25. Howard D.S., Phillips I.G., Reece D.E., Munn R.K., Henslee-Downey J., Pittard M., Barker M., Pomeroy C. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 1999, 29:1494-1501.
26. Huntzinger E., Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 2011, 12:99-110.
27. Hutvagner G., Simard M.J. Argonaute proteins: key players in RNA silencing. Nat. Rev. Mol. Cell Biol. 2008, 9:22-32.
28. Ison M.G. Adenovirus infections in transplant recipients. Clin. Infect. Dis. 2006, 43:331-339.
29. Kawamata T., Tomari Y. Making RISC. Trends Biochem. Sci. 2010, 35:368-376.
30. Kneidinger D., Ibrisimovic M., Lion T., Klein R. Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery. Antiviral Res. 2012, 94:195-207.
31. Kojaoghlanian T., Flomenberg P., Horwitz M.S. The impact of adenovirus infection on the immunocompromised host. Rev. Med. Virol. 2003, 13:155-171.
32. Lenaerts L., De Clercq E., Naesens L. Clinical features and treatment of adenovirus infections. Rev. Med. Virol. 2008, 18:357-374.
33. Lindemans C.A., Leen A.M., Boelens J.J. How i treat adenovirus in hematopoietic stem cell transplant recipients. Blood 2010, 116:5476-5485.
34. Lion T., Baumgartinger R., Watzinger F., Matthes-Martin S., Suda M., Preuner S., Futterknecht B., Lawitschka A., Peters C., Potschger U., Gadner H. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003, 102:1114-1120.
35. Lion T., Kosulin K., Landlinger C., Rauch M., Preuner S., Jugovic D., Potschger U., Lawitschka A., Peters C., Fritsch G., Matthes-Martin S. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia 2010, 24:706-714.
36. Liu Y.P., Berkhout B. MiRNA cassettes in viral vectors: problems and solutions. Biochim. Biophys. Acta 2011, 1809:732-745.
37. Liu Y.P., Haasnoot J., ter Brake O., Berkhout B., Konstantinova P. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res. 2008, 36:2811-2824.
38. Ljungman P., Ribaud P., Eyrich M., Matthes-Martin S., Einsele H., Bleakley M., Machaczka M., Bierings M., Bosi A., Gratecos N., Cordonnier C. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the infectious diseases working party of the european group for blood and marrow transplantation. Bone Marrow Transplant. 2003, 31:481-486.
39. Lu S., Cullen B.R. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis. J. Virol. 2004, 78:12868-12876.
40. Mowa M.B., Crowther C., Arbuthnot P. Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators. Expert Opin. Drug Deliv. 2010, 7:1373-1385.
41. Munoz F.M., Piedra P.A., Demmler G.J. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin. Infect. Dis. 1998, 27:1194-1200.
42. Paolino K., Sande J., Perez E., Loechelt B., Jantausch B., Painter W., Anderson M., Tippin T., Lanier E.R., Fry T., DeBiasi R.L. Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001. J. Clin. Virol. 2011, 50:167-170.
43. Pelka P., Ablack J.N., Fonseca G.J., Yousef A.F., Mymryk J.S. Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J. Virol. 2008, 82:7252-7263.
44. Raoul C., Barker S.D., Aebischer P. Viral-based modelling and correction of neurodegenerative diseases by RNA interference. Gene Ther. 2006, 13:487-495.
45. Rettig G.R., Behlke M.A. Progress toward in vivo use of siRNAs-II. Mol. Ther. 2012, 20:483-512.
46. Sontheimer E.J. Assembly and function of RNA silencing complexes. Nat. Rev. Mol. Cell Biol. 2005, 6:127-138.
47. Symeonidis N., Jakubowski A., Pierre-Louis S., Jaffe D., Pamer E., Sepkowitz K., O'Reilly R.J., Papanicolaou G.A. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl. Infect. Dis. 2007, 9:108-113.
48. Wu Z., Xue Y., Wang B., Du J., Jin Q. Broad-spectrum antiviral activity of RNA interference against four genotypes of Japanese encephalitis virus based on single microRNA polycistrons. PLoS ONE 2011, 6:e26304.
49. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17:3011-3016.
50. Yusuf U., Hale G.A., Carr J., Gu Z., Benaim E., Woodard P., Kasow K.A., Horwitz E.M., Leung W., Srivastava D.K., Handgretinger R., Hayden R.T. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006, 81:1398-1404.
51. Zeng Y., Wagner E.J., Cullen B.R. Both natural and designed microRNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Nat. Rev. Mol. Cell Biol. 2002, 9:1327-1333.
52. Zhou J., Rossi J.J. Progress in RNAi-based antiviral therapeutics. Methods Mol. Biol. 2011, 721:67-75.